scholarly journals Monoclonal antibodies specific for T cell-associated carbohydrate determinants react with human blood group antigens CAD and SDA.

1988 ◽  
Vol 167 (1) ◽  
pp. 119-131 ◽  
Author(s):  
A Conzelmann ◽  
L Lefrancois

The CT antigenic determinants have previously been shown to be present on the T200 glycoproteins and other proteins of murine cytotoxic T cell clones but not of T helper clones or nonactivated lymphocytes (1, 2). Two determinants recognized by mAbs CT1 and CT2 are also expressed on thymocytes in a developmentally regulated fashion during fetal thymus ontogeny and are found in a subset of Lyt-2+ intraepithelial lymphocytes in the intestinal mucosa (3-5). Previous studies of the biosynthesis of CT+ proteins suggested that these determinants were composed of carbohydrate (8). We now demonstrate that the anti-CT mAbs react with a carbohydrate determinant at the nonreducing terminus of O-linked oligosaccharides that has the configuration GalNAc beta 1,4[SA alpha 2,3]-galactose. The CT antibodies detected this determinant not only on CTL clones but also in the human blood group antigens Cad and Sda+. Variant CTL lines, non-Cad erythrocytes, and Sda- glycoproteins that lacked the GalNAc residue did not bind the CT mAb. Sialic acid was essential for CT antigen expression since neuraminidase or mild periodate treatment abrogated CT antibody binding. In addition, other carbohydrate structures with terminal GalNAc residues such as the A or Tn blood group antigens were not recognized. The CT antibodies thus define GalNAc and sialic acid containing carbohydrate antigens that are expressed on discrete subsets of T lymphocytes and may also be useful reagents for the detection of Cad and Sda+ blood group antigens.

1982 ◽  
Vol 60 (1) ◽  
pp. 76-80 ◽  
Author(s):  
Raymond U. Lemieux ◽  
Maria Halina Burzynska

In order to investigate the immunological properties of certain I blood group specific glycoproteins, the potential antigenic determinants βDGlcNAc(1 → 6)αDGalNAc and βDGal(1 → 4)βDGlcNAc(1 → 6)αDGalNAc attached as glycosides to 8-methoxy-carbonyloctanol were synthesized by way of the phthalimido-chloride method.


2010 ◽  
Vol 71 ◽  
pp. S141
Author(s):  
Constanca Figueiredo ◽  
Yarua Jaimes ◽  
Britta Eiz-Vesper ◽  
Axel Seltsam ◽  
Rainer Blasczyk

Transfusion ◽  
2012 ◽  
Vol 52 (12) ◽  
pp. 2620-2630 ◽  
Author(s):  
Nicole H. Smith ◽  
Kate L. Henry ◽  
Chantel M. Cadwell ◽  
Ashley Bennett ◽  
Jeanne E. Hendrickson ◽  
...  

1966 ◽  
Vol 4 (3) ◽  
pp. 250-259 ◽  
Author(s):  
William J. Kuhns ◽  
F. T. Rapaport ◽  
H. S. Lawrence ◽  
J. M. Converse

Blood ◽  
2003 ◽  
Vol 101 (7) ◽  
pp. 2870-2876 ◽  
Author(s):  
Niro Inaba ◽  
Toru Hiruma ◽  
Akira Togayachi ◽  
Hiroko Iwasaki ◽  
Xiao-Hui Wang ◽  
...  

The human blood group i and I antigens are determined by linear and branched poly-N-acetyllactosamine structures, respectively. In erythrocytes, the fetal i antigen is converted to the adult I antigen by I-branching β-1,6-N-acetylglucosaminyltransferase (IGnT) during development. Dysfunction of the I-branching enzyme may result in the adult i phenotype in erythrocytes. However, the I gene responsible for blood group I antigen has not been fully confirmed. We report here a novel human I-branching enzyme, designatedIGnT3. The genes for IGnT1 (reported in 1993),IGnT2 (also presented in this study), and IGnT3consist of 3 exons and share the second and third exons. Bone marrow cells preferentially expressed IGnT3 transcript. During erythroid differentiation using CD34+ cells,IGnT3 was markedly up-regulated with concomitant decrease in IGnT1/2. Moreover, reticulocytes expressed theIGnT3 transcript, but IGnT1/2 was below detectable levels. By molecular genetic analyses of an adult i pedigree, individuals with the adult i phenotype were revealed to have heterozygous alleles with mutations in exon 2 (1006G>A; Gly336Arg) and exon 3 (1049G>A; Gly350Glu), respectively, of the IGnT3gene. Chinese hamster ovary (CHO) cells transfected with each mutatedIGnT3 cDNA failed to express I antigen. These findings indicate that the expression of the blood group I antigen in erythrocytes is determined by a novel IGnT3, not byIGnT1 or IGnT2.


1994 ◽  
Vol 276 (2) ◽  
pp. 239-243
Author(s):  
Pablo Gil-Loyzaga ◽  
Manuel Remezal ◽  
Rosella Mollicone ◽  
Angeles Ib��ez ◽  
Rafael Oriol

Sign in / Sign up

Export Citation Format

Share Document